Contact Lenses/Eye Wear News

Soft contact lens wear resulted in similar rates of microbial keratitis and other inflammatory adverse events in children first fit between ages 8 and 12 years compared with adults.

The majority of eye care providers consider myopia to be one of the biggest problems affecting children’s eyesight; however, only standard vision correction is offered for most of these patients.

2020 was supposed to be the year of vision, which we approached with great excitement. Never in our wildest dreams did we expect to face what we’re experiencing now. And who knows what the future will bring?

A greater need for treatment and awareness of visual impairment issues such as myopia among the population in East Asian countries exists, according to findings published in the British Journal of Ophthalmology.

Visual snow syndrome is a fascinating phenomenon of unknown neurological etiology. Although many clinicians have never even heard of it or consider it rare, my experience suggests it is more common than previously thought.

Executives from SightGlass Vision, developers of novel spectacles designed to slow myopia progression in children, are hoping this treatment option can help address the increasing prevalence of this condition worldwide.

NuEyes has partnered with ThirdEye to introduce the Pro 2 lightweight X2 MR Glasses for patients who have experienced visual impairment uncorrectable by traditional methods.

Evidence-based research on the safety and efficacy of different treatments aided practitioners in managing myopia in children, according to a review published in Ophthalmic and Physiological Optics.

An industry group is concerned over the Federal Trade Commission’s changes to the Contact Lens Rule that permit computer-generated phone calls to verify prescriptions and require more stringent documentation for prescription release.

The Federal Trade Commission announced in a June 23 press release that updates to the Contact Lens Rule will now mandate that doctors who prescribe contact lenses must maintain proof that they released the prescription to the patient for at least 3 years.